|
1
|
Di Tucci C, Capone C, Galati G, Iacobelli
V, Schiavi MC, Di Donato V, Muzii L and Panici PB: Immunotherapy in
endometrial cancer: New scenarios on the horizon. J Gynecol Oncol.
30:e462019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shu S, Liu X, Xu M, Gao X, Fan J, Liu H
and Li R: MicroRNA-424 regulates epithelial-mesenchymal transition
of endometrial carcinoma by directly targeting insulin-like growth
factor 1 receptor. J Cell Biochem. 2018.(Epub ahead of print).
|
|
3
|
Sun P, Mao X, Gao M, Huang MM, Chen LL,
Ruan GY, Huang WY, Braicu EI and Sehouli J: Novel endocrine
therapeutic strategy in endometrial carcinoma targeting
estrogen-related receptor b by XCT790 and siRNA. Cancer Manag Res.
10:2521–2535. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bendifallah S, Ballester M and Darai E:
Endometrial cancer: Predictive models and clinical impact. Bull
Cancer. 104:1022–1031. 2017.(in French). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tran AQ and Gehrig P: Recent advances in
endometrial cancer. F1000Res. 6:812017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wright JD, Burke WM, Wilde ET, Lewin SN,
Charles AS, Kim JH, Goldman N, Neugut AI, Herzog TJ and Hershman
DL: Comparative effectiveness of robotic versus laparoscopic
hysterectomy for endometrial cancer. J Clin Oncol. 30:783–791.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhong W, Feng H, Santiago FE and Kipreos
ET: CUL-4 ubiquitin ligase maintains genome stability by
restraining DNA-replication licensing. Nature. 423:885–889. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Higa LA, Wu M, Ye T, Kobayashi R, Sun H
and Zhang H: CUL4-DDB1 ubiquitin ligase interacts with multiple
WD40-repeat proteins and regulates histone methylation. Nat Cell
Biol. 8:1277–1283. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sharma P and Nag A: CUL4A ubiquitin
ligase: A promising drug target for cancer and other human
diseases. Open Biol. 4:1302172014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin X, Ma YC, Zhu WY and Fan L: CUL4A
expression is associated with tumor stage and prognosis in
nasopharyngeal carcinoma. Medicine (Baltimore). 98:e180362019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nag A, Bagchi S and Raychaudhuri P: Cul4A
physically associates with MDM2 and participates in the proteolysis
of p53. Cancer Res. 64:8152–8155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li B, Jia N, Kapur R and Chun KT: Cul4A
targets p27 for degradation and regulates proliferation, cell cycle
exit, and differentiation during erythropoiesis. Blood.
107:4291–4299. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bian WG, Zhou XN, Song S, Chen HT, Shen Y
and Chen P: Reduced miR-363-3p expression in non-small cell lung
cancer is associated with gemcitabine resistance via targeting of
CUL4A. Eur Rev Med Pharmacol Sci. 23:649–659. 2019.PubMed/NCBI
|
|
16
|
Sui XM, Zhou H, Zhu L, Wang DQ, Fan SM and
Zhao W: CUL4A promotes proliferation and metastasis of colorectal
cancer cells by regulating H3K4 trimethylation in
epithelial-mesenchymal transition. OncoTargets Ther. 10:735–743.
2017. View Article : Google Scholar
|
|
17
|
Han XN, Fang ZL, Wang H, Jiao RF, Zhou J
and Fang N: CUL4A functions as an oncogene in ovarian cancer and is
directly regulated by miR-494. Biochem Biophys Res Commun.
480:675–681. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YS, Liu XY, Zheng H, Wang Q, An L and
Wei GW: Suppression of CUL4A attenuates TGF-β 1-induced
epithelial-to-mesenchymal transition in breast cancer cells. Int J
Mol Med. 40:1114–1124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai L, Wang H and Yang Q: CRKL
overexpression promotes cell proliferation and inhibits apoptosis
in endometrial carcinoma. Oncol Lett. 13:51–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin QY, Chen H, Zhang MF, Xiong HZ and
Jiang QP: Knocking down FAM83B inhibits endometrial cancer cell
proliferation and metastasis by silencing the PI3K/AKT/mTOR
pathway. Biomed Pharmacother. 115:1089392019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang TJ, Xue D, Zhang CD, Zhang ZD, Liu
QR and Wang JQ: Cullin 4A is associated with epithelial to
mesenchymal transition and poor prognosis in perihilar
cholangiocarcinoma. World J Gastroenterol. 23:2318–2329. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hung MS, Chen YC, Lin PY, Li YC, Hsu CC,
Lung JH, You L, Xu Z, Mao JH, Jablons DM and Yang CT: Cul4A
modulates invasion and metastasis of lung cancer through regulation
of ANXA10. Cancers (Basel). 11:6182019. View Article : Google Scholar
|
|
24
|
Wang YS, Liu XY, Zheng H, Wang Q, An L and
Wei GW: [Corrigendum] Suppression of CUL4A attenuates TGF-β
1-induced epithelial-to-mesenchymal transition in breast cancer
cells. Int J Mol Med. 40:16112017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu RF, Cai LM, Chi YG, Ding XC and Wu XQ:
miR-377 targets CUL4A and regulates metastatic capability in
ovarian cancer. Int J Mol Med. 41:3147–3156. 2018.PubMed/NCBI
|
|
26
|
Liu Z, He W, Gao J, Luo J, Huang X and Gao
C: Computational prediction and experimental validation of a novel
synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing
mechanisms in cervical cancer. Oncotarget. 6:8019–8035. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie PM, Wang XL, Kong M, Bai XY and Jiang
T: TRAF4 promotes endometrial cancer cell growth and migration by
activation of PI3K/AKT/Oct4 signaling. Exp Mol Pathol. 108:9–16.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gong Y, Xiang XJ, Feng M, Chen J, Fang ZL
and Xiong JP: CUL4A promotes cell invasion in gastric cancer by
activating the NF-κB signaling pathway. Biologics. 11:45–53.
2017.PubMed/NCBI
|
|
29
|
Xu YY, Wang YS, Ma GX, Wang Q and Wei GW:
CUL4A is overexpressed in human pituitary adenomas and regulates
pituitary tumor cell proliferation. J Neurooncol. 116:625–632.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao ZH, Wang WW, Niu LH, Zhang JY and
Jiang GZ: p53-induced long non-coding RNA PGM5-AS1 inhibits the
progression of esophageal squamous cell carcinoma through
regulating miR-466/PTEN axis. IUBMB Life. 71:1492–1502. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao J, Chen HQ, Yang HF, Li Y, Chen DJ,
Huang YJ, He LX, Zheng CF, Wang LQ, Wang J, et al: Epigenetic
silencing of ALX4 regulates microcystin-LR induced hepatocellular
carcinoma through the P53 pathway. Sci Total Environ. 683:317–330.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De U, Son JY, Sachan R, Park YJ, Kang D,
Yoon K, Lee BM, Kim IS, Moon HR and Kim HS: A new synthetic histone
deacetylase inhibitor, MHY2256, induces apoptosis and autophagy
cell death in endometrial cancer cells via p53 acetylation. Int J
Mol Sci. 19:27432018. View Article : Google Scholar
|
|
33
|
Jhan JH, Lee YC, Li WM, Chang LL, Hsu WC,
Lin HH, Liang PI, Hsu YL, Wu WJ, Lee HY, et al: The prognostic
value of CSN6 expression in upper tract urothelial carcinomas.
Kaohsiung J Med Sci. 35:559–565. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Du WQ, Liu ZX, Zhu WT, Li TT, Zhu Z, Wei
L, Song J and Pei DS: CSN6 promotes tumorigenesis of gastric cancer
by ubiquitin-independent proteasomal degradation of
p16INK4a. Cancer Biol Med. 16:514–529. 2019.PubMed/NCBI
|
|
35
|
Hou J, Deng Q, Zhou J, Zou J, Zhang Y, Tan
P, Zhang W and Cui H: CSN6 controls the proliferation and
metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
Oncogene. 36:1134–1144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang WQ, Tang M, Zhang L, Xu X, Qi X, Yang
Y, Jin F and Chen B: Clinical implications of CSN6 protein
expression and correlation with mutant-type P53 protein in breast
cancer. Jpn J Clin Oncol. 43:1170–1176. 2013. View Article : Google Scholar : PubMed/NCBI
|
